• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个用于基层医疗中高血压和糖尿病护理的综合数字医学平台:一项真实世界可行性测试。

A comprehensive digital medicine platform for hypertension and diabetes care in primary care: A real-world feasibility test.

作者信息

Bae Ye Seul, Park Seoyeon, Noh Changbo, Choi Boram, Yi Seung Ah, Kim So Eun, Kim Yoon Ji, Kang Jae-Heon

机构信息

Big Data Research Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Department of Family Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

出版信息

Digit Health. 2025 May 23;11:20552076251344375. doi: 10.1177/20552076251344375. eCollection 2025 Jan-Dec.

DOI:10.1177/20552076251344375
PMID:40416073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12103660/
Abstract

BACKGROUND

Hypertension and diabetes are typically managed in primary care settings, where continuous and tailored care based on continuity in daily life is essential to improve health outcomes.

OBJECTIVE

To address the shortage of human and material resources in primary care and to enhance health outcomes, we developed and implemented a comprehensive digital medicine platform in a real-world setting.

METHODS

A patient application (app) and a web app for healthcare providers were developed to enable bidirectional communication between patients and healthcare providers. Primary physicians and care coordinators utilized this platform to deliver personalized care management. To manage multiple patients with limited staff, automated message generation logic was used.

RESULTS

Using the app, patients could self-measure blood pressure and blood glucose level, receive feedback from healthcare providers, and obtain personalized medication management, disease education, and lifestyle guidance regarding smoking, alcohol consumption, and exercise. Healthcare providers can view the data generated by the patient app, in real time, on the web app, and immediately send messages when an action is required. An evaluation of effectiveness was conducted with 502 patients in the intervention group and 502 patients in the control group over a 24-week intervention. In the intervention group, systolic blood pressure decreased by 3.8% ( < 0.001), diastolic blood pressure by 3.4% ( < 0.001), body mass index by 1.6% ( < 0.001), and waist circumference by 1.5% ( < 0.001). HDL cholesterol increased by 2.4% ( < 0.05), and triglycerides decreased by 5.4% ( < 0.05).

CONCLUSION

This study demonstrated that the adoption of a digital medicine platform is effective and essential for continuous patient management in primary care. Information and communications technology-based tools and applications are becoming increasingly important in healthcare, and our study has provided valuable insights into the management of chronic diseases.

摘要

背景

高血压和糖尿病通常在基层医疗环境中进行管理,在这种环境下,基于日常生活连续性的持续且个性化的护理对于改善健康结果至关重要。

目的

为了解决基层医疗中人力和物力资源短缺的问题并提高健康结果,我们在实际环境中开发并实施了一个综合数字医学平台。

方法

开发了一个患者应用程序(app)和一个供医疗服务提供者使用的网络应用程序,以实现患者与医疗服务提供者之间的双向沟通。初级医师和护理协调员利用这个平台提供个性化的护理管理。为了在人员有限的情况下管理多名患者,使用了自动消息生成逻辑。

结果

通过该应用程序,患者可以自行测量血压和血糖水平,接收医疗服务提供者的反馈,并获得个性化的药物管理、疾病教育以及关于吸烟、饮酒和运动的生活方式指导。医疗服务提供者可以在网络应用程序上实时查看患者应用程序生成的数据,并在需要采取行动时立即发送消息。在为期24周的干预期间,对干预组的502名患者和对照组的502名患者进行了有效性评估。干预组的收缩压下降了3.8%(<0.001),舒张压下降了3.4%(<0.001),体重指数下降了1.6%(<0.001),腰围下降了1.5%(<0.001)。高密度脂蛋白胆固醇升高了2.4%(<0.05),甘油三酯下降了5.4%(<0.05)。

结论

本研究表明,采用数字医学平台对于基层医疗中持续的患者管理是有效且必不可少的。基于信息和通信技术的工具及应用在医疗保健中变得越来越重要,我们的研究为慢性病管理提供了有价值的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b2/12103660/1260cda019b5/10.1177_20552076251344375-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b2/12103660/59e6ff2fa56c/10.1177_20552076251344375-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b2/12103660/1c9ef6abb4ef/10.1177_20552076251344375-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b2/12103660/3af86f3ae6ad/10.1177_20552076251344375-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b2/12103660/61d75cd22916/10.1177_20552076251344375-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b2/12103660/f602dba9014f/10.1177_20552076251344375-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b2/12103660/1260cda019b5/10.1177_20552076251344375-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b2/12103660/59e6ff2fa56c/10.1177_20552076251344375-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b2/12103660/1c9ef6abb4ef/10.1177_20552076251344375-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b2/12103660/3af86f3ae6ad/10.1177_20552076251344375-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b2/12103660/61d75cd22916/10.1177_20552076251344375-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b2/12103660/f602dba9014f/10.1177_20552076251344375-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b2/12103660/1260cda019b5/10.1177_20552076251344375-fig6.jpg

相似文献

1
A comprehensive digital medicine platform for hypertension and diabetes care in primary care: A real-world feasibility test.一个用于基层医疗中高血压和糖尿病护理的综合数字医学平台:一项真实世界可行性测试。
Digit Health. 2025 May 23;11:20552076251344375. doi: 10.1177/20552076251344375. eCollection 2025 Jan-Dec.
2
Effectiveness of Mobile App-Assisted Self-Care Interventions for Improving Patient Outcomes in Type 2 Diabetes and/or Hypertension: Systematic Review and Meta-Analysis of Randomized Controlled Trials.移动应用辅助自我护理干预在改善 2 型糖尿病和/或高血压患者结局中的有效性:随机对照试验的系统评价和荟萃分析。
JMIR Mhealth Uhealth. 2020 Aug 4;8(8):e15779. doi: 10.2196/15779.
3
Evaluation of the Impact of Mobile Health App Vitadio in Patients With Type 2 Diabetes: Randomized Controlled Trial.移动健康应用程序Vitadio对2型糖尿病患者影响的评估:随机对照试验。
J Med Internet Res. 2025 May 9;27:e68648. doi: 10.2196/68648.
4
Real-World Evidence of a Hospital-Linked Digital Health App for the Control of Hypertension and Diabetes Mellitus in South Korea: Nationwide Multicenter Study.韩国一款与医院相关的数字健康应用程序用于控制高血压和糖尿病的真实世界证据:全国多中心研究
JMIR Form Res. 2023 Aug 21;7:e48332. doi: 10.2196/48332.
5
Personalized Smartphone-Enabled Assessment of Blood Pressure and Its Treatment During the SARS-CoV-2 COVID-19 Pandemic in Patients From the CURE-19 Study: Longitudinal Observational Study.CURE-19研究中患者在2019冠状病毒病(COVID-19)大流行期间基于个性化智能手机的血压评估及其治疗:纵向观察性研究
JMIR Mhealth Uhealth. 2024 Dec 3;12:e53430. doi: 10.2196/53430.
6
Efficacy of a Mobile Health-Based Behavioral Treatment for Lifestyle Modification in Type 2 Diabetes Self-Management: Greenhabit Randomized Controlled Trial.基于移动健康的行为疗法对2型糖尿病自我管理中生活方式改变的疗效:Greenhabit随机对照试验
J Med Internet Res. 2025 Jan 22;27:e58319. doi: 10.2196/58319.
7
Changes in blood pressure among users of lay health worker or volunteer operated community-based blood pressure programs over time: a systematic review protocol.随着时间推移,由非专业卫生工作者或志愿者运营的社区血压项目使用者的血压变化:一项系统评价方案
JBI Database System Rev Implement Rep. 2015 Oct;13(10):30-40. doi: 10.11124/jbisrir-2015-1927.
8
Real-world Benefits of Diabetes Management App Use and Self-monitoring of Blood Glucose on Glycemic Control: Retrospective Analyses.基于真实世界数据的糖尿病管理应用程序使用和自我血糖监测对血糖控制的影响:回顾性分析。
JMIR Mhealth Uhealth. 2022 Jun 15;10(6):e31764. doi: 10.2196/31764.
9
10
Effect of Smartphone-Based Lifestyle Coaching App on Community-Dwelling Population With Moderate Metabolic Abnormalities: Randomized Controlled Trial.基于智能手机的生活方式指导应用对代谢异常的社区居民的影响:随机对照试验。
J Med Internet Res. 2020 Oct 9;22(10):e17435. doi: 10.2196/17435.

本文引用的文献

1
The Effectiveness of an eHealth Family-Based Intervention Program in Patients With Uncontrolled Type 2 Diabetes Mellitus (T2DM) in the Community Via WeChat: Randomized Controlled Trial.基于微信的家庭为基础的电子健康干预方案对社区中未控制的 2 型糖尿病患者的有效性:随机对照试验。
JMIR Mhealth Uhealth. 2023 Mar 20;11:e40420. doi: 10.2196/40420.
2
New wave of digital hypertension management for clinical applications.用于临床应用的数字高血压管理新趋势。
Hypertens Res. 2022 Oct;45(10):1549-1551. doi: 10.1038/s41440-022-00977-2. Epub 2022 Jul 20.
3
Smartphone Apps for Diabetes Medication Adherence: Systematic Review.
用于糖尿病药物依从性的智能手机应用程序:系统评价
JMIR Diabetes. 2022 Jun 21;7(2):e33264. doi: 10.2196/33264.
4
Digital Therapeutics in Hypertension: Evidence and Perspectives.数字疗法在高血压中的应用:证据与展望。
Hypertension. 2022 Oct;79(10):2148-2158. doi: 10.1161/HYPERTENSIONAHA.122.19414. Epub 2022 Jun 21.
5
Health system readiness for non-communicable diseases at the primary care level: a systematic review.基层医疗保健中非传染性疾病卫生系统准备情况:系统评价。
BMJ Open. 2022 Feb 9;12(2):e060387. doi: 10.1136/bmjopen-2021-060387.
6
Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial.数字治疗系统在原发性高血压管理中的疗效:HERB-DH1 关键试验。
Eur Heart J. 2021 Oct 21;42(40):4111-4122. doi: 10.1093/eurheartj/ehab559.
7
Clinical Improvements by Telemedicine Interventions Managing Type 1 and Type 2 Diabetes: Systematic Meta-review.远程医疗干预对 1 型和 2 型糖尿病管理的临床改善:系统荟萃评价。
J Med Internet Res. 2021 Feb 19;23(2):e23244. doi: 10.2196/23244.
8
Management and Prevention Strategies for Non-communicable Diseases (NCDs) and Their Risk Factors.非传染性疾病(NCDs)及其风险因素的管理与预防策略
Front Public Health. 2020 Nov 26;8:574111. doi: 10.3389/fpubh.2020.574111. eCollection 2020.
9
WHO Digital Health Guidelines: a milestone for global health.世界卫生组织数字健康指南:全球健康的一个里程碑。
NPJ Digit Med. 2020 Sep 18;3:120. doi: 10.1038/s41746-020-00330-2. eCollection 2020.
10
Effect of a Mobile Phone-Based Glucose-Monitoring and Feedback System for Type 2 Diabetes Management in Multiple Primary Care Clinic Settings: Cluster Randomized Controlled Trial.基于手机的血糖监测和反馈系统对多基层医疗机构 2 型糖尿病管理的效果:集群随机对照试验。
JMIR Mhealth Uhealth. 2020 Feb 26;8(2):e16266. doi: 10.2196/16266.